KLM Laboratories Pvt. Ltd was listed on 26 August 2023 by the 8base ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). 8base listed 33 organizations that month and 448 in total.
- Listed 1182 days ago.
- 413 organizations were listed by all groups in August 2023, see the month.
- 26 in Healthcare that month.
- 7 in IN that month.
Updated 2026-11-19 06:46 UTC. Data: public leak-site listings. How we work.
Threat Group Post & Evidence
- Listed by
- 8Base 448 listings in total
The listing states no data size and no ransom demand.
No capture of the original post
We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.
The group's leak-site address is on paid plans
Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.
What the group says it holds
Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.
At KLM labs, our commitment, quality and precision makes us one of the most successful pharmaceutical companies. We provide quality healthcare products. KLM laboratories set up its foot in the pharmaceutical industry in 2010 with a vision of providing quality healthcare services to the community. We emerged as the top prescribers of Itraconazole in India in 2013, and we soon ventured into the international markets in 2015, making a thunderous proclamation. In 2017, We expanded our firm and launched a Pediatric Dermatology division. Another milestone was achieved in 2019 when KLM established itself in the domestic market in the Ophthalmology and Orthopedic sector. With over a decade of experience, we are India's top pharmaceutical company in dealing with dermatology, eye care, and ortho care. KLM laboratories global presence is enriched by over 1000 professionals, 55000 doctors affiliatio…
Show the full post (2096 characters)
At KLM labs, our commitment, quality and precision makes us one of the most successful pharmaceutical companies. We provide quality healthcare products. KLM laboratories set up its foot in the pharmaceutical industry in 2010 with a vision of providing quality healthcare services to the community. We emerged as the top prescribers of Itraconazole in India in 2013, and we soon ventured into the international markets in 2015, making a thunderous proclamation. In 2017, We expanded our firm and launched a Pediatric Dermatology division. Another milestone was achieved in 2019 when KLM established itself in the domestic market in the Ophthalmology and Orthopedic sector. With over a decade of experience, we are India's top pharmaceutical company in dealing with dermatology, eye care, and ortho care. KLM laboratories global presence is enriched by over 1000 professionals, 55000 doctors affiliations, over 800 stockists expanded in ten-plus countries. Our firm is dedicated to serving two pharmaceutical divisions- Derma and Cosmo sectors that have built a niche in the international markets. We formulate high-quality tested and approved topical and oral solutions, immunomodulators, corticosteroid, anti-bacterial and anti-fungal solutions, including baby care products like shampoo formulations and moisturizing lotions. Our laboratory also ventures into ophthalmology by providing clinically tested eye drops and tablets. In addition, we also create oral formulations to treat ailments related to the musculoskeletal system. We are recognized as an enterprise that provides consumers access to the best pharmaceutical solutions while following a proactive approach to delivering better offerings that reflect modern medical. Commitment, quality, and precision make us one of the most successful pharmaceutical companies. Our strong beliefs and hardcore values have helped us establish a 'corporate social responsibility. Under this globally recognized aspect, our firm wishes to help humankind with healthcare products that would serve them the purpose of better prognosishttp://klmlab.com
Plain-English summary AI-written
The group says the text describes KLM Laboratories but does not state that it holds any files from the company.
Written by an AI model (openai/gpt-6-luna) from the post above. It can contain mistakes: rely on the quote, not the summary.
What to do about this listing
Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.
If you work with KLM Laboratories Pvt. (customer, supplier or partner)
Within 3 days
- Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
- Ask KLM Laboratories Pvt. directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
- Review what KLM Laboratories Pvt. can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.
Within 30 days
- Keep watching KLM Laboratories Pvt. A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are KLM Laboratories Pvt.
Within 3 days
- Find out what was actually taken The post names no specific kind of data, so no data-specific steps are shown. Check the group's own post and your logs to learn what is claimed and what is real. Why: The listing text names no data types.
- Check regulatory and stakeholder notification duties India: CERT-In directions (2022) require reporting of cyber incidents within 6 hours of noticing them; the Digital Personal Data Protection Act, 2023 adds breach notification duties as its rules take effect. Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: Listing country: India.
General readiness for any ransomware claim (not about this listing)
- Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
- Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
- Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.
Listing details
Listing severity score (heuristic)
91/100 • CRITICALA heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.
External Attack Surface Profile
ASM IntelligenceRun a free passive scan on your own domain to see what an attacker can see from the outside.